Medicinal cannabis wholesaler, Canngea, has been fined almost $60,000 for allegedly failing to provide information requested by the Therapeutic Goods Administration.
The Queensland-based company was issued with three infringement notices after the TGA accused it of withholding details about the supply of therapeutic vaping goods.
The regulator said the failure to comply with its requests allegedly breached “conditions of exemption applicable to the goods”.
Canngea has agreed to pay the $59,400 penalty.
The alleged offences appear to relate to nicotine vapes, with a TGA statement warning that “therapeutic vapes for smoking cessation and the management of nicotine dependence are only available for sale from participating pharmacies, where clinically appropriate”.
“As unapproved goods, therapeutic vaping goods are not subject to pre-market evaluation or approval by the TGA but must comply with specified requirements under the Therapeutic Goods Act 1989,” the regulator said.
“Under the Act, sponsors of therapeutic vaping goods must retain and on request provide certain information to the TGA.
“The information must be provided in a specified form and within a specified timeframe. This includes information relating to supply, and it is an offence to provide information that is false or misleading.”
The regulator reiterated that sponsors of vaping goods are responsible for understanding and complying with their regulatory obligations and warned that action would be taken for non-compliance, including the launch of civil or criminal proceedings.
Cannabiz has approached Canngea for comment.
